100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Concise summary of the Cardiovascular System £7.48   Add to cart

Summary

Concise summary of the Cardiovascular System

2 reviews
 72 views  0 purchase

Detailed summary of the cardiovascular chapter of BNF

Preview 2 out of 11  pages

  • No
  • Chapter 2 - cardiovascular system
  • November 4, 2020
  • 11
  • 2020/2021
  • Summary
book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:
All documents for this subject (27)

2  reviews

review-writer-avatar

By: rubana8 • 1 year ago

review-writer-avatar

By: ayodeledelrah • 2 year ago

Sry it was a typo my bad, really like this, have you got one for MEP to purchase?

reply-writer-avatar

By: anmoll • 2 year ago

Only 1? Any reason?

reply-writer-avatar

By: ayodeledelrah • 2 year ago

Translated by Google

Typo

reply-writer-avatar

By: anmoll • 2 year ago

Okay no worries. I think I do - will try and upload by the end of today. Thanks

reply-writer-avatar

By: anmoll • 2 year ago

Hi, yes I do - please see under 'Summary of the MEP' and 'MEP: Summary of Controlled Drugs'. Hope you find them useful.

avatar-seller
anmoll
2 – Cardiovascular System



Drug Tx options for rhythm control post-
Chapter 2 – cardioversion:
Cardiovascular System 1. Standard BB
2. Sotalol
3. Flecainide or propafenone – avoid in
ARRHYTHMIAS
ischaemic or structural heart disease
Ectopic beats – if spontaneous and in a normal 4. Amiodarone – if necessary, start 4 weeks
heart, Tx with beta-blockers is not required before and continue for up to 12 months
post-electrical cardioversion to increase
Atrial fibrillation
success of procedure and maintain rhythm
 If Tx fails to control symptoms, refer within
Tx for Paroxysmal AF
4 weeks and consider ablation strategies
1. Standard BB or dronedarone, sotalol,
 Review anticoagulation, stroke and bleeding
flecainide, propafenone or amiodarone
risk annually
2. ‘Pill-in-the-pocket’ – useful in Pts with
Acute presentation infrequent episodes. It involves taking
 All Pts with fatal haemodynamic instability flecainide or propafenone to self-treat an
caused by new-onset AF = emergency episode of AF
electrical cardioversion
Stroke prevention
 All Pts with non-fatal haemodynamic
instability = rate or rhythm control if onset Stroke risk:
is < 48 hours or uncertain
Urgent rate control = IV verapamil or a BB
Cardioversion
 If AF is present for >48hrs – electrical
cardioversion is preferred. Do NOT start
until Pt has been anticoagulated for at least
3 weeks. If not possible, use parenteral
Bleeding risk:
anticoagulation
 Pharmacological cardioversion = IV
amiodarone or flecainide acetate
Drug Tx
1st line = rate control except in Pts with new-
onset AF, atrial flutter suitable for ablation, AF
with a reversible cause or if rhythm control is
more suitable based on judgement
Atrial flutter
Rate control options:  Rate control = BB, diltiazem, verapamil,
1. Standard BB (not sotalol) digoxin
2. Verapamil or diltiazem  Rhythm control = electrical cardioversion,
3. Digoxin is only effective for controlling the pharmacological cardioversion, ablation
rate at rest hence use only in sedentary Pts
with non-paroxysmal AF. It’s also used in AF
with congestive heart failure

, 2 – Cardiovascular System


Paroxysmal supraventricular tachycardia arrhythmias or bradyarrhythmias unresponsive
 Usually terminates spontaneously or with to atropine
reflex vagal stimulation like Valsalva
Digoxin – useful for controlling ventricular
manoeuvre, immersing face in cold water or
response in persistent and permanent AF
carotid sinus massage
 Hypokalaemia predisposes Pt to digitalis
Arrythmias post MI toxicity – managed by K+ sparing diuretics
 Treat bradycardia with atropine. If
unresponsive, treat with adrenaline/e BLEEDING DISORDERS

Ventricular tachycardia Tranexamic acid – impairs fibrin dissolution
 Treat ASAP with immediate defibrillation Desmopressin – used in mild-to-mod
 If stable – treat with anti-arrhythmics haemophilia and von Willebrand’s disease
Torsades de pointes – ventricular tachycardia Etamsylate – reduces capillary bleeding in the
associated with a long QT syndrome. presence of a normal number of platelets; it
 Causes = drugs, hypokalaemia, severe doesn’t act by fibrin stabilisation
bradycardia and genetics.
 Tx = magnesium sulfate, beta blocker (not VENOUS THROMBOEMBOLISM
sotalol) or atrial pacing
RFs = low mobility, obesity, malignant disease,
 Avoid anti-arrhythmics (QT prolong risk)
H/O venous thromboembolism, thrombophilic,
Vaughn Williams classification of anti- pregnancy, post-partum, Pts aged >60 years
arrhythmics:
Mechanical prophylaxis: Stockings
- Class I = membrane stabilising drugs
 Provide graduated compression and calf
(lidocaine, flecainide) pressure of 14-15mmHg.
- Class II = beta blockers  Wear during day and night until mobile.
- Class III = amiodarone, sotalol  Avoid in acute stroke and PAD
- Class IV = CCBs (not DHP CCBs)
Pharmacological prophylaxis
Negative ionotropic effect of anti-arrhythmics  Start ASAP or within 14 hours of admission
can be additive. Hypokalaemia can enhance the  RFs for bleeding = acute stroke, etc
arrhythmogenic effect of many drugs  If bleeding risk, only receive
Supraventricular arrhythmias pharmacological prophylaxis if risk of VTE is
 Adenosine = preferred Tx greater than risk of bleeding
 Digoxin = slows ventricular response Surgical Pts
 Verapamil = initial IV dose may be followed
by oral Tx. AVOID in AF in Wolff-Parkinson-  Offer mechanical prophylaxis to Pts with
White syndrome and children major trauma or surgery. Continue until Pt
 Beta blocker (e.g. esmolol, propranolol) – is mobile or discharged from hospital (or for
for rapid control of ventricular rate 30 days in spinal injury, spinal surgery or
cranial surgery)
Supraventricular and ventricular arrhythmias  Offer pharmacological prophylaxis (LMWH,
 Amiodarone – useful when another Tx fails. unfractionated heparin to Pts undergoing
It has a very long half-life. general or orthopaedic surgery
Digoxin-specific antibody – indicated for Tx of  Pharmacological prophylaxis in general
digoxin toxicity associated with ventricular surgery should continue for at least 7 days
post-surgery or until mobile. Extend

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller anmoll. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for £7.48. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

73314 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy revision notes and other study material for 14 years now

Start selling
£7.48
  • (2)
  Add to cart